What interventions should be included in the management of a client showing early signs of sepsis in order to align with the Surviving Sepsis Campaign guidelines? Select All that Apply.

Bone marrow suppression is a common adverse effect of cytotoxic and antimetabolite therapies such as Methotrexate. This condition results in decreased production of blood cells, leading to anemia, leukopenia, and thrombocytopenia. Because the bone marrow is responsible for hematopoiesis, monitoring blood cell counts is essential to evaluate recovery and detect toxicity early. Improvement is primarily reflected in normalization of circulating blood cell lines.

Rationale:
A. A complete blood count (CBC) is the most appropriate laboratory test to monitor improvement in bone marrow suppression. It directly measures white blood cells, red blood cells, hemoglobin, hematocrit, and platelets, all of which are affected by methotrexate toxicity. Rising counts toward normal ranges indicate recovery of bone marrow function and improved hematopoiesis.

B. Renal function tests are important in clients receiving methotrexate because the drug is primarily excreted by the kidneys and can accumulate in renal impairment. However, these values assess drug clearance and toxicity risk rather than recovery from bone marrow suppression. They do not directly reflect improvement in blood cell production.

C. Liver function tests (LFTs) are monitored because methotrexate can cause hepatotoxicity with prolonged use. While they help detect liver injury, they are not indicators of bone marrow recovery. Improvement in bone marrow function is not reflected in hepatic enzyme levels.

D. Blood chemistry panels assess electrolytes and metabolic status, which may be indirectly affected in critically ill patients. However, they do not provide specific information about bone marrow activity or hematologic recovery. Therefore, they are not useful for evaluating improvement in bone marrow suppression.

A Sengstaken-Blakemore tube is used as an emergency measure to control life-threatening bleeding from esophageal varices by applying direct pressure to bleeding sites using inflated gastric and esophageal balloons. This intervention carries significant risks, including airway obstruction, aspiration, and esophageal rupture. Because the tube is placed near the airway and upper gastrointestinal tract, maintaining airway patency and preventing aspiration are the highest priorities during care.

Rationale:
A. Assessing the client for respiratory distress and signs of aspiration is the most critical nursing action because inflation of the balloons can compress the airway and increase the risk of aspiration of blood or gastric contents. Any signs of dyspnea, hypoxia, or coughing may indicate airway compromise, which requires immediate intervention to prevent respiratory failure.

B. Confirming the lumens of the tube are properly labeled is important for correct management of the gastric and esophageal ports but is not the most urgent priority. While proper labeling helps ensure correct inflation and drainage, it does not address immediate life-threatening complications such as airway obstruction or aspiration.

C. Monitoring the gastric balloon pressure every hour is necessary to ensure the balloon is providing adequate tamponade without causing tissue damage or rupture. However, this is a secondary monitoring task compared to airway safety. Overinflation risks esophageal necrosis, but airway protection remains the primary concern.

D. Ensuring the client is in a supine position for comfort is incorrect because the supine position increases the risk of aspiration in a client with active upper gastrointestinal bleeding. The client should typically be positioned with the head elevated or in a lateral position to reduce aspiration risk and support airway protection.